Skip to main content

Pinnacle Hip Implant Plaintiffs Get $245 Million in Damages

Pinnacle Hip Implant Plaintiffs Get $245 Million in Damages

Pinnacle Hip Implant Plaintiffs Get $245 Million in Damages

Introduction

U.S. District Judge Ed Kinkeade bestowed $245 million on six plaintiffs involved in the lawsuits against Johnson & Johnson and its DePuy Orthopaedics, over the alleged Pinnacle Hip Implant defects. The verdict was declared in November 2017, by a federal jury in Dallas.

All these plaintiffs had similar allegations against the company for wrongfully marketing the hip implant used to treat osteoarthritis-related joint failure. The first trial over the Pinnacle Hip Implant defect ended in J&J's favor in 2014; however, subsequent jury trials found the company liable for the design defects in their Metal-on-Metal (MoM).

J&J and DePuy have been accused of failing to warn about devices getting eroded and releasing metal ions, which can lead to metallosis often requiring revision surgery. Over 9,400 Pinnacle Hip lawsuits are pending in the federal court for the complications caused due to the Metal-on-metal (MoM) hip implant. About 28,000 lawsuits have been filed against hip implant makers, involving defendants Zimmer, Stryker, Biomet, Wright, and Smith & Nephew.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!